ES2172182T3 - Composiciones farmaceuticas que comprenden cefuroxima axetil. - Google Patents
Composiciones farmaceuticas que comprenden cefuroxima axetil.Info
- Publication number
- ES2172182T3 ES2172182T3 ES98940001T ES98940001T ES2172182T3 ES 2172182 T3 ES2172182 T3 ES 2172182T3 ES 98940001 T ES98940001 T ES 98940001T ES 98940001 T ES98940001 T ES 98940001T ES 2172182 T3 ES2172182 T3 ES 2172182T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical compositions
- axetil
- cefuroxima
- precipitate
- making
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Un coprecipitado de cefuroxima axetil y un excipiente hidrosoluble. Procedimiento de fabricación de dicho coprecipitado y composiciones farmacéuticas para administración por vía oral que contienen dicho coprecipitado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002209868A CA2209868C (en) | 1997-08-15 | 1997-08-15 | Pharmaceutical compositions comprising cefuroxime axetil |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2172182T3 true ES2172182T3 (es) | 2002-09-16 |
Family
ID=4161029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98940001T Expired - Lifetime ES2172182T3 (es) | 1997-08-15 | 1998-08-07 | Composiciones farmaceuticas que comprenden cefuroxima axetil. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0996449B1 (es) |
AT (1) | ATE213416T1 (es) |
AU (1) | AU8847098A (es) |
CA (1) | CA2209868C (es) |
DE (1) | DE69803930T2 (es) |
ES (1) | ES2172182T3 (es) |
WO (1) | WO1999008683A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT937727E (pt) * | 1998-02-20 | 2002-07-31 | Fako Ilaclari A S | Processo para a producao de cefuroxima azetil cristalina soluvel |
CA2239331C (en) * | 1998-05-29 | 1999-11-30 | Bernard Charles Sherman | Pharmaceutical tablets comprising cefuroxime axetil |
AT413647B (de) * | 1998-11-26 | 2006-04-15 | Sandoz Ag | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
CA2280925A1 (en) | 1999-07-29 | 2001-01-29 | Bernard Charles Sherman | Stabilized cefuroxime axetil |
CZ12993U1 (cs) * | 2001-11-23 | 2003-02-10 | Glaxo Group Limited | Farmaceutický prostředek |
WO2005002540A2 (en) * | 2003-07-01 | 2005-01-13 | Ranbaxy Laboratories Limited | Dry powder pharmaceutical suspension compositions of cefuroxime axetil |
US20090175952A1 (en) * | 2004-01-09 | 2009-07-09 | Jong Soo Woo | Cefuroxime axetil granule and process for the preparation thereof |
CN100402035C (zh) * | 2005-07-07 | 2008-07-16 | 石药集团中奇制药技术(石家庄)有限公司 | 一种微囊化头孢呋辛酯的药物组合物 |
DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
CN101890023B (zh) * | 2010-08-16 | 2013-03-27 | 海南日中天制药有限公司 | 头孢呋辛酯口服剂及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
GB8320521D0 (en) * | 1983-07-29 | 1983-09-01 | Glaxo Group Ltd | Chemical process |
GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
ZA881301B (en) * | 1987-02-27 | 1989-10-25 | Lilly Co Eli | Sustained release matrix formulations |
NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
IT1277426B1 (it) * | 1995-08-03 | 1997-11-10 | Acs Dobfar Spa | Forma cristallina biodisponibile del cefuroxima axetil |
DE19631085A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut |
IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
-
1997
- 1997-08-15 CA CA002209868A patent/CA2209868C/en not_active Expired - Fee Related
-
1998
- 1998-08-07 DE DE69803930T patent/DE69803930T2/de not_active Expired - Fee Related
- 1998-08-07 ES ES98940001T patent/ES2172182T3/es not_active Expired - Lifetime
- 1998-08-07 AU AU88470/98A patent/AU8847098A/en not_active Abandoned
- 1998-08-07 AT AT98940001T patent/ATE213416T1/de not_active IP Right Cessation
- 1998-08-07 EP EP98940001A patent/EP0996449B1/en not_active Revoked
- 1998-08-07 WO PCT/CA1998/000773 patent/WO1999008683A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69803930D1 (de) | 2002-03-28 |
CA2209868C (en) | 2001-08-14 |
CA2209868A1 (en) | 1999-02-15 |
AU8847098A (en) | 1999-03-08 |
WO1999008683A1 (en) | 1999-02-25 |
ATE213416T1 (de) | 2002-03-15 |
DE69803930T2 (de) | 2002-10-17 |
EP0996449B1 (en) | 2002-02-20 |
EP0996449A1 (en) | 2000-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE9900441A (et) | Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks | |
FR2705566B1 (fr) | Nouvelles compositions pharmaceutiques. | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
RS50485B (sr) | Terapeutske kombinacije koje sadrže amplodipin i atorvastatin | |
EE200000320A (et) | Uudsed ühendid | |
SE9704544D0 (sv) | Novel compounds | |
HUP0000839A2 (hu) | Ciklosporint és egy anionos felületaktív szert tartalmazó szilárd gyógyszerkészítmények és eljárás ezek előállítására | |
TR199701018T1 (xx) | Oral 2-metil-tieno-benzodiazepin form�lasyonu. | |
AU7052698A (en) | Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates | |
HUP9900391A2 (hu) | Rapamicineket tartalmazó gyógyszerkészítmények | |
HUP9800688A2 (hu) | Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények | |
HK1029060A1 (en) | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin | |
NO991405L (no) | Belagt partikkelformulering | |
FR2764889B1 (fr) | Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant | |
RS49723B (sr) | Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze | |
NO972391L (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
ES2172182T3 (es) | Composiciones farmaceuticas que comprenden cefuroxima axetil. | |
GB9907571D0 (en) | Compounds | |
MX9704034A (es) | Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso. | |
PT1131297E (pt) | Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores | |
FR2674755B1 (fr) | Nouvelles compositions medicamenteuses immunostimulatrices. | |
YU87501A (sh) | Farmaceutski kompleksi | |
NO910186L (no) | Fremgangsmaate for fremstilling av et oralt inhalerbart, farmasoeytisk atropin-salbutamol-aerosolpreparat. | |
SE9003902D0 (sv) | Solid dosage forms of a drug | |
ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 996449 Country of ref document: ES |